Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Stud Health Technol Inform ; 284: 295-299, 2021 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-34920529

RESUMO

The potential value of AI to healthcare, and nursing in particular, ranges from improving quality and efficiency of care to delivering on the promise of personalized and precision medicine. AI systems may become virtually indispensable as ever more data is amassed about every aspect of health. AI can help reduce variability in care, while improving precision, accelerating discovery and reducing disparities. AI can empower patients and potentially allow healthcare professionals to relate to their patients as healers supported by the combined wisdom of the best medical research and analytic technology. There are, however, many challenges to understanding the optimal uses of AI; addressing the technological, systemic, regulatory and attitudinal roadblocks to successful implementation; and integrating AI into the fabric of health care. This paper provides a grounding in the origins and fundamental building blocks of AI, applications in healthcare and for nursing, and the critical challenges facing implementation in healthcare.


Assuntos
Pesquisa Biomédica , Instalações de Saúde , Inteligência Artificial , Atenção à Saúde , Pessoal de Saúde , Humanos
2.
JAMA Cardiol ; 2(6): 608-616, 2017 06 01.
Artigo em Inglês | MEDLINE | ID: mdl-28384800

RESUMO

Importance: Cohort studies have reported increased incidence of cardiovascular disease (CVD) among individuals with low vitamin D status. To date, randomized clinical trials of vitamin D supplementation have not found an effect, possibly because of using too low a dose of vitamin D. Objective: To examine whether monthly high-dose vitamin D supplementation prevents CVD in the general population. Design, Setting, and Participants: The Vitamin D Assessment Study is a randomized, double-blind, placebo-controlled trial that recruited participants mostly from family practices in Auckland, New Zealand, from April 5, 2011, through November 6, 2012, with follow-up until July 2015. Participants were community-resident adults aged 50 to 84 years. Of 47 905 adults invited from family practices and 163 from community groups, 5110 participants were randomized to receive vitamin D3 (n = 2558) or placebo (n = 2552). Two participants retracted consent, and all others (n = 5108) were included in the primary analysis. Interventions: Oral vitamin D3 in an initial dose of 200 000 IU, followed a month later by monthly doses of 100 000 IU, or placebo for a median of 3.3 years (range, 2.5-4.2 years). Main Outcomes and Measures: The primary outcome was the number of participants with incident CVD and death, including a prespecified subgroup analysis in participants with vitamin D deficiency (baseline deseasonalized 25-hydroxyvitamin D [25(OH)D] levels <20 ng/mL). Secondary outcomes were myocardial infarction, angina, heart failure, hypertension, arrhythmias, arteriosclerosis, stroke, and venous thrombosis. Results: Of the 5108 participants included in the analysis, the mean (SD) age was 65.9 (8.3) years, 2969 (58.1%) were male, and 4253 (83.3%) were of European or other ethnicity, with the remainder being Polynesian or South Asian. Mean (SD) baseline deseasonalized 25(OH)D concentration was 26.5 (9.0) ng/mL, with 1270 participants (24.9%) being vitamin D deficient. In a random sample of 438 participants, the mean follow-up 25(OH)D level was greater than 20 ng/mL higher in the vitamin D group than in the placebo group. The primary outcome of CVD occurred in 303 participants (11.8%) in the vitamin D group and 293 participants (11.5%) in the placebo group, yielding an adjusted hazard ratio of 1.02 (95% CI, 0.87-1.20). Similar results were seen for participants with baseline vitamin D deficiency and for secondary outcomes. Conclusions and Relevance: Monthly high-dose vitamin D supplementation does not prevent CVD. This result does not support the use of monthly vitamin D supplementation for this purpose. The effects of daily or weekly dosing require further study. Trial Registration: clinicaltrials.gov Identifier: ACTRN12611000402943.


Assuntos
Doenças Cardiovasculares/prevenção & controle , Colecalciferol/administração & dosagem , Deficiência de Vitamina D/tratamento farmacológico , Vitaminas/administração & dosagem , Idoso , Idoso de 80 Anos ou mais , Angina Pectoris/epidemiologia , Angina Pectoris/prevenção & controle , Arritmias Cardíacas/epidemiologia , Arritmias Cardíacas/prevenção & controle , Arteriosclerose/epidemiologia , Arteriosclerose/prevenção & controle , Doenças Cardiovasculares/epidemiologia , Doenças Cardiovasculares/mortalidade , Colecalciferol/uso terapêutico , Suplementos Nutricionais , Método Duplo-Cego , Feminino , Insuficiência Cardíaca/epidemiologia , Insuficiência Cardíaca/prevenção & controle , Humanos , Hipertensão/epidemiologia , Hipertensão/prevenção & controle , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/epidemiologia , Infarto do Miocárdio/prevenção & controle , Nova Zelândia , Modelos de Riscos Proporcionais , Acidente Vascular Cerebral/epidemiologia , Acidente Vascular Cerebral/prevenção & controle , Trombose Venosa/epidemiologia , Trombose Venosa/prevenção & controle , Deficiência de Vitamina D/epidemiologia , Vitaminas/uso terapêutico
3.
J Steroid Biochem Mol Biol ; 164: 318-325, 2016 11.
Artigo em Inglês | MEDLINE | ID: mdl-26365555

RESUMO

Observational studies have shown that low vitamin D status is associated with an increased risk of cardiovascular disease, acute respiratory infection, falls and non-vertebral fractures. We recruited 5110 Auckland adults, aged 50-84 years, into a randomized, double-blind, placebo-controlled trial to test whether vitamin D supplementation protects against these four major outcomes. The intervention is a monthly cholecalciferol dose of 100,000IU (2.5mg) for an estimated median 3.3 years (range 2.5-4.2) during 2011-2015. Participants were recruited primarily from family practices, plus community groups with a high proportion of Maori, Pacific, or South Asian individuals. The baseline evaluation included medical history, lifestyle, physical measurements (e.g. blood pressure, arterial waveform, lung function, muscle function), and a blood sample (stored at -80°C for later testing). Capsules are being mailed to home addresses with a questionnaire to collect data on non-hospitalized outcomes and to monitor adherence and potential adverse effects. Other data sources include New Zealand Ministry of Health data on mortality, hospitalization, cancer registrations and dispensed pharmaceuticals. A random sample of 438 participants returned for annual collection of blood samples to monitor adherence and safety (hypercalcemia), including repeat physical measurements at 12 months follow-up. The trial will allow testing of a priori hypotheses on several other endpoints including: weight, blood pressure, arterial waveform parameters, heart rate variability, lung function, muscle strength, gait and balance, mood, psoriasis, bone density, and chronic pain.


Assuntos
Acidentes por Quedas/prevenção & controle , Doenças Cardiovasculares/prevenção & controle , Colecalciferol/administração & dosagem , Suplementos Nutricionais , Fraturas Ósseas/prevenção & controle , Infecções Respiratórias/prevenção & controle , Afeto/efeitos dos fármacos , Idoso , Idoso de 80 Anos ou mais , Pressão Sanguínea/efeitos dos fármacos , Pressão Sanguínea/fisiologia , Doenças Cardiovasculares/metabolismo , Doenças Cardiovasculares/patologia , Método Duplo-Cego , Feminino , Fraturas Ósseas/metabolismo , Fraturas Ósseas/patologia , Marcha/efeitos dos fármacos , Marcha/fisiologia , Frequência Cardíaca/efeitos dos fármacos , Frequência Cardíaca/fisiologia , Humanos , Masculino , Pessoa de Meia-Idade , Força Muscular/efeitos dos fármacos , Cooperação do Paciente , Equilíbrio Postural/efeitos dos fármacos , Projetos de Pesquisa , Testes de Função Respiratória , Infecções Respiratórias/metabolismo , Infecções Respiratórias/patologia , Inquéritos e Questionários
4.
Health Aff (Millwood) ; 33(3): 487-92, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24590950

RESUMO

The 1976 Supreme Court decision in Estelle v. Gamble declared that jails must provide medical treatment to detainees consistent with community standards of care. Yet despite their important role providing health care to about ten million people a year, jails remain largely siloed from the surrounding health care community, compromising inmates' health and adding to health care spending. Health information technology promises solutions. The current policy landscape, shaped by the Health Information Technology for Economic and Clinical Health (HITECH) Act and the Affordable Care Act, is favorable to jails' implementation of health information technology (IT). In this article we examine how decisions largely external to jails-coming from the Supreme Court, Congress, and local policy makers-have contributed to the growth of health IT within jails and health information exchange between jails and local communities. We also discuss privacy concerns under the Health Insurance Portability and Affordability Act and other legislation. This article highlights a rare confluence of events that could improve the health of an overlooked population.


Assuntos
Serviços de Saúde Comunitária/tendências , Comportamento Cooperativo , Atenção à Saúde/tendências , Política de Saúde/tendências , Comunicação Interdisciplinar , Informática Médica/tendências , Patient Protection and Affordable Care Act/tendências , Prisões/tendências , Serviços de Saúde Comunitária/economia , Atenção à Saúde/economia , Previsões , Política de Saúde/economia , Acessibilidade aos Serviços de Saúde/economia , Acessibilidade aos Serviços de Saúde/tendências , Necessidades e Demandas de Serviços de Saúde/economia , Necessidades e Demandas de Serviços de Saúde/tendências , Humanos , Masculino , Medicaid/economia , Medicaid/tendências , Informática Médica/economia , Patient Protection and Affordable Care Act/economia , Grupo Associado , Prisões/economia , Apoio Social , Estados Unidos , Adulto Jovem
5.
Health Aff (Millwood) ; 32(2): 376-84, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23381531

RESUMO

Patient-centered care is considered one pillar of a high-performing, high-quality health care system. It is a key component of many efforts to transform care and achieve better population health. Expansion of health information technology and consumer e-health tools--electronic tools and services such as secure e-mail messaging between patients and providers, or mobile health apps--have created new opportunities for individuals to participate actively in monitoring and directing their health and health care. The Office of the National Coordinator for Health Information Technology in the Department of Health and Human Services leads the strategy to increase electronic access to health information, support the development of tools that enable people to take action with that information, and shift attitudes related to the traditional roles of patients and providers. In this article we review recent evidence in support of consumer e-health and present the federal strategy to promote advances in consumer e-health to increase patient engagement, improve individual health, and achieve broader health care system improvements.


Assuntos
Sistemas de Informação em Saúde , Participação do Paciente/métodos , Registros Eletrônicos de Saúde , Custos de Cuidados de Saúde , Humanos , Informática Médica , Educação de Pacientes como Assunto/métodos , Direitos do Paciente , Qualidade da Assistência à Saúde/organização & administração , Confiança , Estados Unidos
6.
Nurs Econ ; 29(1): 35-7, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21469488

RESUMO

We need to consider how the health care system should revolve around the patient, rather than the patient rotating around the hospital. Considering a patient-centric point of view when implementing and optimizing the use of health information technology (HIT) provides new perspectives on the meaning of "integrated" health care. ot only do we need to give patients the opportunities to participate as true partners in their health care, we must convince them why this partnership makes sense. We should not be naive and believe all patients want this involvement in their care today and are ready to do all their health care transactions electronically. But considering and using these practices are important steps in the health care reform journey to improve quality and decrease cost. Many patients will benefit by our working with them to demystify the health care experience through patient-centric practices and the use of HIT.


Assuntos
Assistência Centrada no Paciente , Atenção à Saúde/organização & administração , Hospitalização , Atenção Primária à Saúde
7.
Healthc Inform ; 28(12): 31-5, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22233015

RESUMO

While there is no shortcut to meaningful use, getting the fundamentals right is essential to smoothing the way to qualifying for incentives.


Assuntos
Difusão de Inovações , Registros Eletrônicos de Saúde/estatística & dados numéricos , Sistemas de Informação Hospitalar , Reembolso de Incentivo , Centers for Medicare and Medicaid Services, U.S. , Eficiência Organizacional , Estados Unidos
9.
Nurs Econ ; 28(4): 283-6, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-21761616

RESUMO

The American Recovery and Reinvestment Act and its important Health Information Technology Act provision became law on February 17, 2009. Commonly referred to as "The Stimulus Bill" or "The Recovery Act," the landmark legislation allocated $787 billion to stimulate the economy, including $147 billion to rescue and reform the nation's seriously ailing health care industry. Of these funds, $19 billion in financial incentives were earmarked for the relatively short period of 5 years to drive reform through the use of advanced health information technology (HIT) and the adoption of electronic health records (EHRs). he incentives were intended to help health care providers purchase and implement HIT and EHR systems, and the HITECH Act also stipulated clear penalties would be imposed beyond 2015 for both hospitals and physician providers who failed to adopt use of EHRs in a meaningful way. Nurses will be integral to achieving a vision that will require a nationwide effort to adopt and implement EHR systems in a meaningful way.


Assuntos
Sistemas Computadorizados de Registros Médicos/estatística & dados numéricos , Sistemas Computadorizados de Registros Médicos/economia , Sistemas Computadorizados de Registros Médicos/legislação & jurisprudência , Sistemas Computadorizados de Registros Médicos/normas , Informática em Enfermagem , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA